Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann M Decker

Showing results (81-90 of 86) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 86 results.
Translational Oncology|February 22, 2023
HER2 as a potential therapeutic target on quiescent prostate cancer cellsKenji Yumoto, Jibraan Rashid, Kristina G Ibrahim, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 6, 2025
An antifentanyl monoclonal antibody reverses fentanyl-induced apnea in pigsCarly Baehr, Eduardo Hatschbach, Jennifer Vigliaturo, et al.
Cancer Research|February 13, 2018
CXCL12γ Promotes Metastatic Castration-Resistant Prostate Cancer by Inducing Cancer Stem Cell and Neuroendocrine PhenotypesYounghun Jung, Frank C Cackowski, Kenji Yumoto, et al.
Cancer Research|November 16, 2021
Correction: CXCL12γ Promotes Metastatic Castration-Resistant Prostate Cancer by Inducing Cancer Stem Cell and Neuroendocrine PhenotypesYounghun Jung, Frank C Cackowski, Kenji Yumoto, et al.
ACS Chemical Neuroscience|September 15, 2015
Novel Synthesis and Pharmacological Characterization of NOP Receptor Agonist 8-[(1S,3aS)-2,3,3a,4,5,6-Hexahydro-1H-phenalen-1-yl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one (Ro 64-6198)Steven D Chang, Lawrence E Brieaddy, Joseph D Harvey, et al.
Biological Psychiatry|May 30, 2026
Targeting Mu opioid receptor neurons of the habenula to limit naloxone aversionDersu Ozdemir, Chiara Ebner, Judith Meyer, et al.
Pageof 9

Showing results (81-90 of 86) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
Translational Oncology|February 22, 2023
HER2 as a potential therapeutic target on quiescent prostate cancer cellsKenji Yumoto, Jibraan Rashid, Kristina G Ibrahim, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 6, 2025
An antifentanyl monoclonal antibody reverses fentanyl-induced apnea in pigsCarly Baehr, Eduardo Hatschbach, Jennifer Vigliaturo, et al.
Cancer Research|February 13, 2018
CXCL12γ Promotes Metastatic Castration-Resistant Prostate Cancer by Inducing Cancer Stem Cell and Neuroendocrine PhenotypesYounghun Jung, Frank C Cackowski, Kenji Yumoto, et al.
Cancer Research|November 16, 2021
Correction: CXCL12γ Promotes Metastatic Castration-Resistant Prostate Cancer by Inducing Cancer Stem Cell and Neuroendocrine PhenotypesYounghun Jung, Frank C Cackowski, Kenji Yumoto, et al.
ACS Chemical Neuroscience|September 15, 2015
Novel Synthesis and Pharmacological Characterization of NOP Receptor Agonist 8-[(1S,3aS)-2,3,3a,4,5,6-Hexahydro-1H-phenalen-1-yl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one (Ro 64-6198)Steven D Chang, Lawrence E Brieaddy, Joseph D Harvey, et al.
Biological Psychiatry|May 30, 2026
Targeting Mu opioid receptor neurons of the habenula to limit naloxone aversionDersu Ozdemir, Chiara Ebner, Judith Meyer, et al.
Pageof 9